Vaccine News and Research

Latest Vaccine News and Research

More companies offering on-site health care services for workers

The Philadelphia Inquirer on Wednesday examined how workplace-based health care centers are "quickly gaining popularity among large employers around the country" who consider them "an attractive perk for employees, but also a way to increase worker productivity and hold down health costs by treating problems early and efficiently."

4 Sep 2008

Anadis to commercialise "BioGard" adjunctive therapy for HIV/AIDS

Anadis announced today its commercialization of a new product, BioGard, intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS.

4 Sep 2008

CDC MMR/autism study - wrong questions asked, wrong children studied, wrong conclusions NAA says

A Centers for Disease Control and Prevention (CDC) study released today claims there is no link between the MMR vaccine and autism. The National Autism Association (NAA) says this study does nothing to dispel the growing public concern over a vaccine-autism connection and raises several questions concerning design and methodology.

4 Sep 2008

CDC MMR/autism study - wrong questions asked, wrong children studied, wrong conclusions NAA says

4 Sep 2008

Most vaccine-allergic children can still be safely vaccinated

With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center. Writing in the September issue of Pediatrics, the multicenter research team offers pediatricians a step-by-step tool for quickly identifying children with allergic reactions to vaccines, and a much-needed guide, they say, to safely immunize those who are allergic.

2 Sep 2008

Infectious Disease Research Institute receives $6.3 million NIAID grant to study TB vaccine

Seattle's Infectious Disease Research Institute on Tuesday announced it has received a $6.3 million grant from NIH's National Institute of Allergy and Infectious Diseases to study a new tuberculosis vaccine, the Puget Sound Business Journal reports (Puget Sound Business Journal, 8/27).

29 Aug 2008

Shots are nothing to shy away from with the right approach

"Getting shots may seem burdensome and even downright scary to some children, but they protect children against dangerous and deadly diseases."

28 Aug 2008

Recent advances make cervical cancer control in developing world feasible for first time

Recent advances in cervical cancer prevention mean that controlling the disease in developing countries is becoming feasible for the first time, experts say.

28 Aug 2008

Uganda's Makerere University receives AMANET grant for malaria vaccine trial

The College of Health Sciences at Uganda's Makerere University will receive a grant from the African Malaria Network Trust to begin trials of the malaria vaccine candidate GMZ2 in Uganda's Iganga and Mayuge districts, Wen Kilama, managing trustee of AMANET, said Monday at the opening of the sixth Basic Research Ethics Workshop for African Ethics Committees, the New Vision reports.

28 Aug 2008

Hunt for baby denied HBV shot

Authorities in New South Wales, Australia, continue to search for a couple who have refused to have their newborn baby immunised against hepatitis B.

25 Aug 2008

Infant deaths in clinical drug trials in India raise concern about ethical standards

The revelation that 49 babies died at a top Indian hospital during drug tests has shocked many and raised issues concerning ethical standards at the hospital.

25 Aug 2008

New vaccine to fight multiple influenza strains

A universal vaccine effective against several strains of influenza has passed its first phase of testing, according to Dr. Christine Turley of the University of Texas at Galveston.

21 Aug 2008

Bacterial pneumonia caused most deaths in 1918 influenza pandemic

The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Instead, most victims succumbed to bacterial pneumonia following influenza virus infection.

19 Aug 2008

Antibodies to 1918 flu pandemic may provide means to tackle bird flu threat

Scientists in the United States have discovered that elderly survivors of the original 1918 flu pandemic, still have immunity to the virus.

18 Aug 2008

Pancreatitis link to Gardasil to be investigated by the TGA

Some Australian doctors are suggesting that a review of the cervical cancer vaccine Gardasil is called for after three patients contracted pancreatitis after having the vaccination.

18 Aug 2008

Alternative vaccine strategy shows promise in prostate cancer patients

New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.

17 Aug 2008

Portable test for bird flu promises to save many lives

An easily portable device which tests for bird flu in humans promises to save lives by cutting the time it takes to spot potentially lethal cases down to a few hours.

14 Aug 2008

NanoBio vaccine for hepatitis B shows promise

Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. The disease and its complications cause an estimated 1 million deaths globally each year.

13 Aug 2008

Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs

AIDS experts at Johns Hopkins say they have compelling evidence that some people with HIV who for years and even decades show extremely low levels of the virus in their blood never progress to full-blown AIDS and remain symptom free even without treatment, probably do so because of the strength of their immune systems, not any defects in the strain of HIV that infected them in the first place.

12 Aug 2008

Australian doctors call for a national immunisation register

The Australian Medical Association (AMA) has welcomed the announcement of a new national register of human papilloma virus (HPV) vaccinations but says it would be more cost effective to create a register for all vaccinations.

11 Aug 2008